SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kwality Pharma - Quaterly Results

06 Feb 2024 Evaluate
The sales moved up 39.43% to Rs. 780.95 millions for the December 2023 quarter as compared to Rs. 560.10 millions during the year-ago period.Modest increase of 6.62% in the Net Profit was reported from. 72.26 millions to Rs. 77.04  millions.The company reported a good operating profit of 173.21 millions compared to 155.24 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 780.95 560.10 39.43 2151.95 1821.92 18.11 2509.95 4561.32 -44.97
Other Income 6.18 3.52 75.57 12.48 14.81 -15.73 29.41 35.12 -16.26
PBIDT 173.21 155.24 11.58 470.24 502.50 -6.42 632.29 1752.37 -63.92
Interest 27.33 19.50 40.15 73.29 43.52 68.41 60.20 29.17 106.38
PBDT 145.88 135.74 7.47 396.95 458.98 -13.51 406.80 1723.20 -76.39
Depreciation 48.12 35.44 35.78 144.68 105.02 37.76 149.19 106.44 40.16
PBT 97.76 100.30 -2.53 252.27 353.96 -28.73 257.61 1616.76 -84.07
TAX 20.72 28.04 -26.11 58.19 85.72 -32.12 62.92 416.28 -84.89
Deferred Tax -3.88 2.79 -239.07 -6.13 -0.30 1943.33 1.37 2.75 -50.18
PAT 77.04 72.26 6.62 194.08 268.24 -27.65 194.69 1200.48 -83.78
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 22.18 27.72 -19.98 21.85 27.58 -20.77 25.19 38.42 -34.43

Kwality Pharma Share Price

1662.05 -2.25 (-0.14%)
21-Apr-2026 09:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.95
Dr. Reddys Lab 1242.75
Cipla 1230.00
Zydus Lifesciences 935.00
Lupin 2337.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×